Analgesic Efficacy of Naproxen-Codeine, Naproxen Plus Dexamethasone, and Naproxen on Myofascial Pain: a Randomized Double-Blind Controlled Trial
dc.authorid | Cigerim, Levent/0000-0001-5218-8568 | |
dc.authorid | Kaplan, Volkan/0000-0002-7605-1125 | |
dc.authorscopusid | 55318687000 | |
dc.authorscopusid | 56789733600 | |
dc.authorwosid | Kaplan, Volkan/Aba-6258-2020 | |
dc.contributor.author | Cigerim, Levent | |
dc.contributor.author | Kaplan, Volkan | |
dc.date.accessioned | 2025-05-10T17:09:19Z | |
dc.date.available | 2025-05-10T17:09:19Z | |
dc.date.issued | 2023 | |
dc.department | T.C. Van Yüzüncü Yıl Üniversitesi | en_US |
dc.department-temp | [Cigerim, Levent] Van Yuzuncu Yil Univ, Dept Oral & Maxillofacial Surg, Fac Dent, Van, Turkey; [Kaplan, Volkan] Tekirdag Namik Kemal Univ, Dept Oral & Maxillofacial Surg, Fac Dent, TR-59100 Tekirdag, Turkey | en_US |
dc.description | Cigerim, Levent/0000-0001-5218-8568; Kaplan, Volkan/0000-0002-7605-1125 | en_US |
dc.description.abstract | Objective To assess the effects of naproxen sodium-codeine phosphate, naproxen sodium-dexamethasone, and naproxen sodium on myofascial pain. Methods This randomized, double-blind prospective clinical study was conducted with patients who applied with the complaint of pain in the temporomandibular region. A total of 169 patients were randomly divided into four groups and received the following treatments: Group A: naproxen sodium 550 mg; Group B: naproxen sodium 550 mg + codeine phosphate 30 mg; Group C: naproxen sodium 550 mg + single-dose dexamethasone 8 mg, and Group D: paracetamol 500 mg. Results Of the patients, 132 were female, and 37 were male, with a mean age of 27.04 +/- 10.56 (18-69 years). Analgesic efficiency of the naproxen sodium-codeine phosphate group was the most effective at the 2nd week and 4th week (p< 0.05). Conclusion Naproxen sodium-codeine phosphate might be preferred as an analgesic in similar cases with severe myofascial pain. | en_US |
dc.description.woscitationindex | Science Citation Index Expanded | |
dc.identifier.doi | 10.1080/08869634.2020.1824411 | |
dc.identifier.endpage | 125 | en_US |
dc.identifier.issn | 0886-9634 | |
dc.identifier.issn | 2151-0903 | |
dc.identifier.issue | 2 | en_US |
dc.identifier.pmid | 32941116 | |
dc.identifier.scopus | 2-s2.0-85091078291 | |
dc.identifier.scopusquality | Q2 | |
dc.identifier.startpage | 119 | en_US |
dc.identifier.uri | https://doi.org/10.1080/08869634.2020.1824411 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14720/7109 | |
dc.identifier.volume | 41 | en_US |
dc.identifier.wos | WOS:000570273800001 | |
dc.identifier.wosquality | N/A | |
dc.language.iso | en | en_US |
dc.publisher | Taylor & Francis Ltd | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Temporomandibular Disorders | en_US |
dc.subject | Codeine | en_US |
dc.subject | Naproxen | en_US |
dc.subject | Dexamethasone | en_US |
dc.subject | Pain | en_US |
dc.title | Analgesic Efficacy of Naproxen-Codeine, Naproxen Plus Dexamethasone, and Naproxen on Myofascial Pain: a Randomized Double-Blind Controlled Trial | en_US |
dc.type | Article | en_US |